Host genetics contributes to the effectiveness of dendritic cell-based HIV immunotherapy (2018)
Reis, Edione Cristina dos; Silva, Lais Teodoro da; Silva, Wanessa Cardoso da; Rios, Alexandre; Duarte, Alberto José da Silva; Sumida, Telma Miyuki Oshiro; Crovella, Sergio; Pontillo, Alessandra 
Source: Human vaccines & immunotherapeutics. Unidades: FM, ICB, IB
Subjects: HIV, IMUNOTERAPIA, IMUNOGENÉTICA, CÉLULAS DENDRÍTICAS, POLIMORFISMO, IMUNIZAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
REIS, Edione Cristina dos et al. Host genetics contributes to the effectiveness of dendritic cell-based HIV immunotherapy. Human vaccines & immunotherapeutics, v. 14, n. 8, p. 1995-2002, 2018Tradução . . Disponível em: https://doi.org/10.1080/21645515.2018.1463942. Acesso em: 12 nov. 2024.APA
Reis, E. C. dos, Silva, L. T. da, Silva, W. C. da, Rios, A., Duarte, A. J. da S., Sumida, T. M. O., et al. (2018). Host genetics contributes to the effectiveness of dendritic cell-based HIV immunotherapy. Human vaccines & immunotherapeutics, 14( 8), 1995-2002. doi:10.1080/21645515.2018.1463942NLM
Reis EC dos, Silva LT da, Silva WC da, Rios A, Duarte AJ da S, Sumida TMO, Crovella S, Pontillo A. Host genetics contributes to the effectiveness of dendritic cell-based HIV immunotherapy [Internet]. Human vaccines & immunotherapeutics. 2018 ; 14( 8): 1995-2002.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1080/21645515.2018.1463942Vancouver
Reis EC dos, Silva LT da, Silva WC da, Rios A, Duarte AJ da S, Sumida TMO, Crovella S, Pontillo A. Host genetics contributes to the effectiveness of dendritic cell-based HIV immunotherapy [Internet]. Human vaccines & immunotherapeutics. 2018 ; 14( 8): 1995-2002.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1080/21645515.2018.1463942
